AIFMD Delegated Regulation: Difference between revisions
Jump to navigation
Jump to search
Amwelladmin (talk | contribs) (Created page with "http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32013R0231 {{aifmdanatomy}}") |
Amwelladmin (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32013R0231 | {{euregulation|231|2013}} http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32013R0231 | ||
{{aifmdanatomy}} | {{aifmdanatomy}} | ||
Latest revision as of 12:02, 30 January 2015
231/2013 (EUR Lex) http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32013R0231
AIFMD
This is an article about Alternative Investment Funds Management Directive (2011/61/EU (EUR Lex)) and the AIFMD Implementing Regulation 231/2013 (EUR Lex).
Navigation - directive 2011/61/EU (EUR Lex): 21 | 21(8) | 21(11) | 21(14) | 36 (depo-lite) | 36(1)
Navigation - implementing regulation 231/2013 (EUR Lex): DR76 (objective reason) | DR91 (reporting obligations for prime brokers)
AIFMD Anatomy
Anatomy™: AIFMD | CASS | COBS | Conference calls | Confis | CRR | CSA | EMIR | Equity Derivatives | FOA PCA | FUND | GMRA | GMSLA | ISDA | OSLA | PB | Swapclear | UCITS